Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs USFR✓SelectedUSD · USFRMRNA vs USFR performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs USFR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
USFR return
+21.5%
Excess return
-52.5%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioUSFRExcessAlpha
1D-2.2%0.0%-2.2%-2.3%
7D-12.7%+0.1%-12.8%-13.2%
30D-20.7%+0.4%-21.0%-22.8%
3M+46.3%+1.1%+45.2%+35.9%
6M+305.2%+2.1%+303.2%+270.5%
YTD+561.2%+3.6%+557.7%+482.9%
1Y+772.1%+4.1%+768.0%+660.6%
3Y+147.0%+14.4%+132.6%+49.6%
All-31.0%+21.5%-52.5%-84.8%

Cumulative growth

Daily Returns

Daily percentage return beside USFR.

Daily Out/Under-Performance

Portfolio return minus USFR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × USFR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded USFR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling